FTRE Stock Analysis: Buy, Sell, or Hold?
FTRE - Fortrea Holdings Inc. Common Stock
$16.46
0.90 (5.78%)
▲
5d:
-1.02%
30d:
+25.27%
90d:
+68.82%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When FTRE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: FTRE shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: FTRE shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$31.45
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$19.53
15.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: FTRE is currently trading at $16.46, which is considered fair relative to its 30-day fair value range of $13.86 to $16.47. The stock's valuation (Forward PE: 15.3) is in line with its historical norms (15.0). At these levels, the market is pricing in 0.7% annual earnings growth.
Technical Outlook: Technically, FTRE is in a strong uptrend. Immediate support is located at $13.11, while resistance sits at $17.56. The stock is showing strong short-term momentum, up 5.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, FTRE is in a strong uptrend. Immediate support is located at $13.11, while resistance sits at $17.56. The stock is showing strong short-term momentum, up 5.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$13.86 -
$16.47
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
75.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.8%)
- NEUTRAL: Near Wall St target ($16.21)
- BULLISH: Expecting earnings turnaround to 0.7% growth with -2.3% revenue growth
Trading Range Analysis
30-Day Trading Range
$13.86 -
$16.47
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$13.11
Resistance Level
$17.56
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.29
Wall Street Target
$16.21
(-1.5%)
Revenue Growth (YoY)
-2.3%
Earnings Growth (YoY)
-57.4%
Profit Margin
-16.5%
Valuation Premium vs History
+0.7% premium
PE vs Historical
15.3 vs 15.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.7%
(market-implied from PE analysis)
1-Year Target
$16.58
(+1%)
2-Year Target
$16.69
(+1%)
3-Year Target
$16.81
(+2%)
3-Yr Target (if PE normalizes)
(PE: 15→15)
PE COMPRESSION
$16.49
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 33.5%)
$55.78
(+239%)
Base:
(SPY PE: 15.3, Growth: 33.5%)
$39.15
(+138%)
Bear:
(PE: 13.0, Growth: 33.5%)
$33.28
(+102%)
Share & Embed Analysis
Last updated: June 23, 2026 11:41 PM ET
Data refreshes hourly during market hours. Next update: 12:41 AM
Data refreshes hourly during market hours. Next update: 12:41 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FTRE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Jill G Mcconnell
SELL
1804 shares
2026-03-16
Jill G Mcconnell
SELL
5061 shares
2026-03-10
Robert Parks
SELL
1927 shares
2026-03-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 56 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 57 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 67 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
